A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 43 400 KRW 2.72%
Market Cap: 989.5B KRW

Operating Margin
AprilBio Co Ltd

-17.2%
Current
-1 042%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17.2%
=
Operating Profit
-1.5B
/
Revenue
9B

Operating Margin Across Competitors

No Stocks Found

AprilBio Co Ltd
Glance View

Market Cap
977.7B KRW
Industry
Biotechnology

AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.

Intrinsic Value
19 101.15 KRW
Overvaluation 56%
Intrinsic Value
Price
A
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17.2%
=
Operating Profit
-1.5B
/
Revenue
9B
What is the Operating Margin of AprilBio Co Ltd?

Based on AprilBio Co Ltd's most recent financial statements, the company has Operating Margin of -17.2%.

Back to Top